Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500000 participants
OBSERVATIONAL
2016-01-01
2035-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the early stage of the project team's analysis of refractive error after high myopia cataract surgery, it was found that the accuracy of intraocular lens calculation formula, which is widely recommended for high myopia cataract at present, is still worrying, because most of these formulas are based on the European and American eye data, while the European and American databases have few ultra high myopia data, which greatly affects the formula's accuracy In addition, the calculation of the existing formula needs to include multiple biometric indicators, and can be obtained based on complex algorithms. Artificial intelligence technology is exactly an effective means to solve this kind of problem. Therefore, based on the data of Asian population with high myopia and high incidence, the establishment of an intelligent model for the accurate calculation of high myopia cataract IOL will greatly improve the measurement accuracy Sex.
Therefore, the purpose of this study is to establish a multi-center artificial intelligence model for the accurate calculation of intraocular lens and its clinical application in highly myopic cataract, so as to improve the accuracy of the prediction of postoperative diopter in highly myopic cataract patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Highly myopic cataract patients without fundus defects
Highly myopic cataract patients with fundus defects
newly-invented AI model
Apply newly-invented AI models to assist in determining surgical plans and outcome prediction.
Highly myopic cataract patients with fundus defects
newly-invented AI model
Apply newly-invented AI models to assist in determining surgical plans and outcome prediction.
Highly myopic cataract patients with lens grading of NC2-3
newly-invented AI model
Apply newly-invented AI models to assist in determining surgical plans and outcome prediction.
Highly myopic cataract patients with lens grading of NC4-5
newly-invented AI model
Apply newly-invented AI models to assist in determining surgical plans and outcome prediction.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
newly-invented AI model
Apply newly-invented AI models to assist in determining surgical plans and outcome prediction.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Preoperative anterior segment photography and cataract severity assessment, along with fundus OCT examination, have been performed.
If surgical treatment is conducted, the postoperative follow-up period should be no less than 1 month.
There are no missing clinical data before and after the surgery.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eye and ENT Hospital of Fudan University
UNKNOWN
Shanghai High Myopia Study Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
XIANGJIA ZHU
Role: STUDY_CHAIR
Eye & ENT Hospital of Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eye and ENT Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SYA202006
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
SHDC12019X08
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
NSFC-81970780
Identifier Type: -
Identifier Source: org_study_id